Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Tardive Dyskinesia

• Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
• Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
• A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
• Reduction of Demoralization After Treatment of TD With Valbenazine
• Pimavanserin Treatment in TS
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
• The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
• Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
• Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia
• Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia
• Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
• Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia
• Addressing Involuntary Movements in Tardive Dyskinesia
• A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia
• Reducing Involuntary Movements in Participants With Tardive Dyskinesia
• Aim to Reduce Movements in Tardive Dyskinesia
• A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia
• Dysport for the Treatment of OMD
• Pyridoxal Kinase Activity in Tardive Dyskinesia
• NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
• NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
• Xenazine in Late Dyskinetic Syndrome With Neuroleptics
• NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
• Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
• Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia
• Tardive Dyskinesia and Cognitive Function
• Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
• Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
• Extract of Ginkgo Biloba and Tardive Dyskinesia
• Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
• The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
• Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
• Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia
• Levetiracetam Treatment of Tardive Dyskinesia
• Piracetam for Treatment Tardive Dyskinesia
• Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
• Treatment of Tardive Dyskinesia With Galantamine
• Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia